Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYildirim, Hasan Cagri
dc.contributor.authorKapar, Caner
dc.contributor.authorKoksal, Baris
dc.contributor.authorSeyyar, Mustafa
dc.contributor.authorSanci, Pervin Can
dc.contributor.authorGuliyev, Murad
dc.contributor.authorPerkin, Perihan
dc.contributor.authorBuyukkor, Mustafa
dc.contributor.authorYaslikaya, Sendag
dc.contributor.authorMajidova, Nargiz
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorOzaskin, Duygu
dc.contributor.authorAvci, Tugay
dc.contributor.authorGunes, Tugce Kubra
dc.contributor.authorArcagok, Murat
dc.contributor.authorTopal, Alper
dc.contributor.authorKeskin, Gul Sema Yildiran
dc.contributor.authorKavgaci, Gozde
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorCelayir, Ozde Melisa
dc.contributor.authorAvci, Nilufer
dc.contributor.authorAslan, Ferit
dc.contributor.authorAlkan, Ali
dc.contributor.authorErciyestepe, Mert
dc.contributor.authorCengiz, Muhammet
dc.contributor.authorPehlivan, Metin
dc.contributor.authorGulmez, Ahmet
dc.contributor.authorBeypinar, Ismail
dc.contributor.authorTuylu, Tugba Basoglu
dc.contributor.authorKayikcioglu, Erkan
dc.contributor.authorChalabiyev, Elvin
dc.contributor.authorTurhal, Serdal
dc.contributor.authorGuzel, Halil Goksel
dc.contributor.authorAyas, Eyyup
dc.contributor.authorSahbazlar, Mustafa
dc.contributor.authorDulgar, Ozgecan
dc.contributor.authorDemir, Hacer
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorBayoglu, Vedat
dc.contributor.authorSalim, Derya Kivrak
dc.contributor.authorOzturk, Banu
dc.contributor.authorOzdemir, Feyyaz
dc.contributor.authorKara, Oguz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorBal, Oznur
dc.contributor.authorDemirci, Nebi Serkan
dc.contributor.authorYilmaz, Mesut
dc.contributor.authorCabuk, Devrim
dc.contributor.authorAksoy, Sercan
dc.date.accessioned2025-10-16T15:13:38Z
dc.date.issued2025
dc.identifier.doi10.1080/1120009X.2024.2330835
dc.identifier.otherWOS:001187079800001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5895
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceJOURNAL OF CHEMOTHERAPY
dc.subjectPremenopausal breast cancer
dc.subjectlow\\-dose treatment
dc.titleEfficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS